A detailed history of Wilbanks Smith & Thomas Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wilbanks Smith & Thomas Asset Management LLC holds 41,861 shares of ABBV stock, worth $6.96 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
41,861
Previous 34,415 21.64%
Holding current value
$6.96 Million
Previous $5.33 Million 42.92%
% of portfolio
0.22%
Previous 0.16%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $1.19 Million - $1.36 Million
7,446 Added 21.64%
41,861 $7.62 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $1.79 Million - $2.02 Million
-13,037 Reduced 27.47%
34,415 $5.33 Million
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $1.76 Million - $2.04 Million
-13,208 Reduced 21.77%
47,452 $7.07 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $116,476 - $144,947
879 Added 1.47%
60,660 $8.17 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $1.03 Million - $1.18 Million
7,103 Added 13.48%
59,781 $9.53 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $2.74 Million - $3.29 Million
19,814 Added 60.29%
52,678 $8.52 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $17,715 - $20,318
132 Added 0.4%
32,864 $4.41 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $250,881 - $318,952
1,823 Added 5.9%
32,732 $5.01 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $2.23 Million - $2.76 Million
-16,860 Reduced 35.29%
30,909 $4.62 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $212,926 - $269,413
1,982 Added 4.33%
47,769 $6.47 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $108,528 - $123,195
1,020 Added 2.28%
45,787 $4.94 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $220,835 - $246,023
2,099 Added 4.92%
44,767 $5.04 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $132,683 - $146,068
1,297 Added 3.14%
42,668 $4.62 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $105,200 - $142,031
1,307 Added 3.26%
41,371 $4.43 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $113,401 - $133,095
1,320 Added 3.41%
40,064 $3.51 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $59,282 - $79,329
808 Added 2.13%
38,744 $3.8 Million
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $522,450 - $792,099
8,100 Added 27.15%
37,936 $2.89 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $693,385 - $867,573
9,613 Added 47.53%
29,836 $2.64 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $5,983 - $7,193
-95 Reduced 0.47%
20,223 $1.53 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $15,439 - $19,735
235 Added 1.17%
20,318 $1.48 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $18,282 - $21,517
-237 Reduced 1.17%
20,083 $0
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $52,548 - $64,806
-675 Reduced 3.22%
20,320 $1.87 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $185,021 - $205,686
-2,081 Reduced 9.02%
20,995 $1.99 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $10,863 - $12,853
-121 Reduced 0.52%
23,076 $2.14 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $11,593 - $15,524
-126 Reduced 0.54%
23,197 $2.2 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $115,263 - $126,396
-1,287 Reduced 5.23%
23,323 $2.26 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $83,470 - $106,617
-1,195 Reduced 4.63%
24,610 $2.19 Million
Q2 2017

Aug 15, 2017

BUY
N/A
25,805
25,805 $1.87 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.